Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients
Maria Stendahl(Region Jönköpings län), Göran Landberg(Sahlgrenska University Hospital)
Cited by 166
Related Papers
Hypoxia, Snail and incomplete epithelial–mesenchymal transition in breast cancer
|British Journal of Cancer|2009|168
Cyclin D1, Id1 and EMT in breast cancer
|BMC Cancer|2011|145
Downregulation of miR-92a Is Associated with Aggressive Breast Cancer Features and Increased Tumour Macrophage Infiltration
|PLoS ONE|2012|89
Sortilin inhibition limits secretion-induced progranulin-dependent breast cancer progression and cancer stem cell expansion
|Breast Cancer Research|2018|76
Down-Regulation of the Oncogene Cyclin D1 Increases Migratory Capacity in Breast Cancer and Is Linked to Unfavorable Prognostic Features
|American Journal Of Pathology|2010|63